FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315866102> ?p ?o ?g. }

• W4315866102 endingPage "116677" @default.
• W4315866102 startingPage "116677" @default.
• W4315866102 abstract "The high rate of relapse in craniofacial disharmony treatment via trans-sutural distraction osteogenesis (TSDO) is due to the failure to form a stable bone bridge in the suture gap. Bisphosphonates (BP) have a high propensity to localize to hydroxyapatite in the bone matrix and are commonly used as targeting ligands for local delivery of therapeutics into bone microenvironment. Bone-targeted Bortezomib (BP-Btz) is chemosynthetic by linking Btz (Bortezomib) to a BP residue and could target bone tissue to promote osteoblast differentiation and inhibit osteoclastogenesis. Here, suture-derived mesenchymal stem cells (SuSCs) and osteoclasts were treated with Btz and BP-Btz. Aforesaid drugs were injected locally into the sagittal sutures to explore their effects in TSDO. Further, pharmacological properties of BP-Btz in the suture expansion model were assessed by fluorescent BP analogs and levels of total ubiquitinated (Ub)-proteins. The results showed that BP-Btz could stimulate osteogenic differentiation of SuSCs, bind to bone matrix and inhibit osteoclastogenesis. Biological effects of BP-Btz were similar with those of Btz in osteoblast differentiation and osteoclastogenesis inhibition in vitro. Activated bone metabolism were detected after 14 days in the sagittal suture expansion model. Increased osteoid area, remarkably decreased osteoclast surface and enhanced osteogenesis were detected in vivo after treatment with BP-Btz. Green fluorescence signal detection and pharmacodynamic studies revealed that BP-Btz bound to suture edge, released Btz in remodeling conditions, had a higher local concentration and sustained longer than free Btz. This study delineated the clinical potential of bone-targeted Btz conjugate as an efficacious strategy to promote trans-sutural distraction osteogenesis." @default.
• W4315866102 created "2023-01-13" @default.
• W4315866102 creator A5005200123 @default.
• W4315866102 creator A5010212263 @default.
• W4315866102 creator A5021507808 @default.
• W4315866102 creator A5024124240 @default.
• W4315866102 creator A5029548510 @default.
• W4315866102 creator A5036324986 @default.
• W4315866102 creator A5039087813 @default.
• W4315866102 creator A5047763068 @default.
• W4315866102 creator A5053725057 @default.
• W4315866102 creator A5062831432 @default.
• W4315866102 date "2023-04-01" @default.
• W4315866102 modified "2023-10-17" @default.
• W4315866102 title "Bone-targeted bortezomib increases bone formation within Calvarial trans-sutural distraction osteogenesis" @default.
• W4315866102 cites W1514688551 @default.
• W4315866102 cites W1771974095 @default.
• W4315866102 cites W1929611763 @default.
• W4315866102 cites W1963853457 @default.
• W4315866102 cites W1970751450 @default.
• W4315866102 cites W1991341595 @default.
• W4315866102 cites W1992422220 @default.
• W4315866102 cites W1993722891 @default.
• W4315866102 cites W2009897665 @default.
• W4315866102 cites W2012017615 @default.
• W4315866102 cites W2015902352 @default.
• W4315866102 cites W2016521092 @default.
• W4315866102 cites W2017267215 @default.
• W4315866102 cites W2025579499 @default.
• W4315866102 cites W2031314023 @default.
• W4315866102 cites W2032401090 @default.
• W4315866102 cites W2035092031 @default.
• W4315866102 cites W2039923434 @default.
• W4315866102 cites W2050107109 @default.
• W4315866102 cites W2053590482 @default.
• W4315866102 cites W2055802170 @default.
• W4315866102 cites W2058773371 @default.
• W4315866102 cites W2064353445 @default.
• W4315866102 cites W2068208801 @default.
• W4315866102 cites W2069181244 @default.
• W4315866102 cites W2076857416 @default.
• W4315866102 cites W2090030720 @default.
• W4315866102 cites W2101386850 @default.
• W4315866102 cites W2134660260 @default.
• W4315866102 cites W2140258076 @default.
• W4315866102 cites W2154516862 @default.
• W4315866102 cites W2156728273 @default.
• W4315866102 cites W2157107040 @default.
• W4315866102 cites W2167859307 @default.
• W4315866102 cites W2168424657 @default.
• W4315866102 cites W2174907845 @default.
• W4315866102 cites W2265505396 @default.
• W4315866102 cites W2281586158 @default.
• W4315866102 cites W2297139832 @default.
• W4315866102 cites W2407469927 @default.
• W4315866102 cites W2560311906 @default.
• W4315866102 cites W2561763422 @default.
• W4315866102 cites W2598774659 @default.
• W4315866102 cites W2769693026 @default.
• W4315866102 cites W2797362895 @default.
• W4315866102 cites W2810751740 @default.
• W4315866102 cites W2885195721 @default.
• W4315866102 cites W2890119584 @default.
• W4315866102 cites W2981274029 @default.
• W4315866102 cites W3002298756 @default.
• W4315866102 cites W3003587301 @default.
• W4315866102 cites W3030787150 @default.
• W4315866102 cites W3033225111 @default.
• W4315866102 cites W3082966628 @default.
• W4315866102 cites W3087137198 @default.
• W4315866102 cites W3118244582 @default.
• W4315866102 cites W3147997572 @default.
• W4315866102 cites W4205936672 @default.
• W4315866102 cites W4206380168 @default.
• W4315866102 cites W4361867869 @default.
• W4315866102 cites W58878489 @default.
• W4315866102 doi "https://doi.org/10.1016/j.bone.2023.116677" @default.
• W4315866102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36646264" @default.
• W4315866102 hasPublicationYear "2023" @default.
• W4315866102 type Work @default.
• W4315866102 citedByCount "0" @default.
• W4315866102 crossrefType "journal-article" @default.
• W4315866102 hasAuthorship W4315866102A5005200123 @default.
• W4315866102 hasAuthorship W4315866102A5010212263 @default.
• W4315866102 hasAuthorship W4315866102A5021507808 @default.
• W4315866102 hasAuthorship W4315866102A5024124240 @default.
• W4315866102 hasAuthorship W4315866102A5029548510 @default.
• W4315866102 hasAuthorship W4315866102A5036324986 @default.
• W4315866102 hasAuthorship W4315866102A5039087813 @default.
• W4315866102 hasAuthorship W4315866102A5047763068 @default.
• W4315866102 hasAuthorship W4315866102A5053725057 @default.
• W4315866102 hasAuthorship W4315866102A5062831432 @default.
• W4315866102 hasConcept C126322002 @default.
• W4315866102 hasConcept C169760540 @default.
• W4315866102 hasConcept C170033053 @default.
• W4315866102 hasConcept C170493617 @default.
• W4315866102 hasConcept C185592680 @default.
• W4315866102 hasConcept C202751555 @default.

• next